Bionomics IPO Presentation Deck
December 2021, 38 slides
  1. Bionomics
  2. Related Decks
  3. IPO Presentation Decks
to improve the lives of nee with disorders corporate presentation no a confidential bionomics | Bionomics
safe harbor statement | Bionomics
offering summary | Bionomics
emerging leader in neuropsychiatry i stenoses bionomics a a aes a | Bionomics
piper | Bionomics
i bionomics | Bionomics
a differentiated approach the nicotinic acetylcholine receptor | Bionomics
sir harnessing the power of a novel mechanism | Bionomics
in social anxiety disorder | Bionomics
targeting a large segment of the anxiety market sir a disorder that substantially impacts many people | Bionomics
controlled study in healthy volunteers who induced | Bionomics
i | Bionomics
| Bionomics
rapid onset of action is potentially well positioned for social anxiety disorder | Bionomics
lin | Bionomics
in post traumatic stress disorder teem | Bionomics
tackling the profound disease burden of post traumatic stress disorder | Bionomics
amplified fear | Bionomics
potentially addresses the shortcomings of existing therapies potential to treat a | Bionomics
is potentially well positioned in post traumatic stress disorder | Bionomics
| Bionomics
phase attune study underway attune study randomized placebo controlled oral tablet secondary primary on decrease screening to | Bionomics
focused collaborations teem | Bionomics
a partnership | Bionomics
at a daily news | Bionomics
emerging pipeline for partnering | Bionomics
| Bionomics
gain loss of function associated with human pain syndromes where extreme functional selectivity for voltage gated sodium channels and potentially mem compounds synthesized lead candidate identified compound ree observed to reverse pain in the paw | Bionomics
investment highlights stock and financial information | Bionomics
stock and financial snapshot warrants outstanding us a significant investors value fund | Bionomics
bionomics outlook renewed value driving trajectory | Bionomics
appendix prior clinical trial information | Bionomics
summary of clinical trials excellent safety and tolerability profile in healthy subjects and patients a | Bionomics
| Bionomics
trial overall conclusions teem | Bionomics
target bionomics | Bionomics
appendix building value through legacy oncology assets mem | Bionomics
i legacy oncology asset monetization to drive value exclusive oncology license agreement teem exclusive agreement to license bionomics oncology | Bionomics
See More
Bionomics
IPO Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Anxiety
Clinical trial
Clinical development
Drug candidate
Recent decks by Bionomics
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
June 2022
Investor Presentation
April 2022
See all presentations by Bionomics (5 decks)
Related decks
MindMed
Investor Presentation
June 2023
BenevolentAI
Results
March 2023
23andMe
Investor Presentation
January 2024
MindMed
Investor Presentation
April 2021
Avenue Therapeutics
IPO
October 2022
BenevolentAI
Investor Presentation
October 2022
Legend Biotech
Investor Presentation
April 2025
MindMed
Investor Presentation
December 2024
Recent decks by Bionomics
See all presentations (5 decks)
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
June 2022
Investor Presentation
April 2022
MindMed
Investor Presentation
June 2023
BenevolentAI
Results
March 2023
23andMe
Investor Presentation
January 2024
MindMed
Investor Presentation
April 2021
Avenue Therapeutics
IPO
October 2022
BenevolentAI
Investor Presentation
October 2022
Legend Biotech
Investor Presentation
April 2025
MindMed
Investor Presentation
December 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io